Investigating how sleep health affects suicide risk in at-risk adolescents
The Role of Sleep Health in Proximal Suicide Risk among Ultra-High Risk Adolescents
This study is looking at how sleep problems might affect the risk of suicide in teenagers aged 14 to 18 who are facing serious challenges, and it aims to help understand this connection better over an 8-week period.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-10795094 on NIH RePORTER |
What this research studies
This research focuses on understanding the relationship between sleep health and suicide risk among adolescents aged 14 to 18 who are at ultra-high risk. By conducting an 8-week study, researchers will assess various dimensions of sleep disturbances and their potential links to suicidal thoughts and behaviors. The study will involve a transdiagnostic sample of participants who have recently entered Intensive Outpatient or Partial Hospitalization Programs, allowing for a comprehensive evaluation of how sleep interacts with emotional and cognitive factors related to suicidality.
Who could benefit from this research
Good fit: Ideal candidates for this research are adolescents aged 14 to 18 who are currently enrolled in intensive mental health treatment programs and are considered at ultra-high risk for suicide.
Not a fit: Patients outside the age range of 14 to 18 or those not experiencing significant mental health challenges may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved strategies for identifying and mitigating suicide risk in adolescents by addressing sleep health.
How similar studies have performed: Previous research has indicated a significant link between sleep disturbances and suicidality, suggesting that this approach has the potential for meaningful insights.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Goldstein, Tina R — University of Pittsburgh at Pittsburgh
- Study coordinator: Goldstein, Tina R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.